10 apr: Tre effektive måder at reducere din formue på
12 apr: Minimalistisk pragtvilla i Sverige
10-04-2012 14:45:00

Corning To Buy Bulk Of Becton Dickinson's Lab Products Unit For $730 Million In Cash

Relateret indhold

DOW JONES NEWSWIRES

Corning Inc. (GLW) plans to pay roughly $730 million in cash to acquire the bulk of Becton Dickinson & Co.'s (BDX) lab products business, snapping up a portfolio it said will significantly increase its presence in the life-sciences market.

With sales of roughly $235 million expected this year, Corning Chief Executive Wendell P. Weeks said the Discovery Labware unit will expand Corning's annual life-sciences revenue by 40% and move it closer to its goal of being a $1 billion business by 2014.

"The Discovery Labware unit's extensive product portfolio and established dealer network will significantly improve Corning Life Sciences' offerings to customers and is a critical part of Corning's long-term growth strategy," Weeks said.

The purchase, seen closing later this year, excludes the unit's advanced bioprocessing platform. It is expected to begin adding to Corning's earnings in 2013.

"Life Sciences is an attractive growth industry and has low capital intensity. We expect this acquisition to provide a stable stream of incremental cash flow to Corning as we become a more balanced company," said Corning Chief Financial Officer James B. Flaws.

Corning, the world's largest maker of liquid-crystal-display glass for TVs has been struggling recently as lackluster television demand has created a massive headwind for electronics retailers, set manufacturers and suppliers like Corning. The company in January reported its fourth-quarter profit slumped 53% and said it plans to cut capacity in its LCD glass business, as weak demand is leading to "significant" price declines.

Corning shares were recently up 10 cents to $13.58 in premarket trading. Shares of Becton Dickinson were also trading slightly higher at $77.25.

-By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

(END) Dow Jones Newswires

April 10, 2012 08:45 ET (12:45 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Novo-rival spår effekt af ugentligt GLP-1 på linje med Ozempics

13-12-2017 13:30:09
Novo Nordisks store franske rival Sanofi forudser, at dens ugentlige GLP-1-analog, Efpeglenatid, har en effekt på langtidsblodsukkeret, der er på linje Novos nye ugentlige diabetes 2-middel Ozempic, som tilhører samme lægemiddelklasse.Det fremgår af en præsentation under et analytikerarrangement onsdag, hvor Sanofi fremlægger sin forsknings- og udviklingsstrategi for de kommende år.Sanofi indledte..

Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

13-12-2017 09:56:25
Novo Nordisks store franske rival, Sanofi, vil ligesom Novo i de kommende år også fokusere på udviklingen af fedmemedicin og medicin til behandling af leversygdommen, NASH.Det fremgår af en pressemeddelelse i forbindelse med et analytikerarrangement onsdag, hvor Sanofi vil præsentere sin forsknings- og udviklingsstrategi for de kommende år.Sanofis udviklingsindsats inden for forretningsområdet, di..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas får sin største ordre nogensinde i Indien - NY
2
Aktier/tendens: Genmab og Vestas fortsætter i fokus
3
Vestas rykker nærmere kæmpekontrakter i New Mexico og Texas
4
Vestas ejer mere end 5 pct. egne aktier efter opkøb
5
KORR: TK Development-formand køber aktier for 1,9 mio. kr.

Relaterede aktiekurser

Corning Incorporated 32,56 -0,2% Fald i aktiekurs
Becton Dickinson and Com.. 220,34 0,6% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
13. december 2017 17:38:43
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB3 - 2017-12-13 17:38:43 - 2017-12-13 17:38:43 - 1 - Website: OKAY